545 related articles for article (PubMed ID: 12883190)
1. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
2. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
3. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
4. Saying "Yes" to obese living liver donors: short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation.
Perkins JD
Liver Transpl; 2006 Jun; 12(6):1012-3. PubMed ID: 16721781
[TBL] [Abstract][Full Text] [Related]
5. Effect of graft steatosis on liver function and organ survival after liver transplantation.
Angele MK; Rentsch M; Hartl WH; Wittmann B; Graeb C; Jauch KW; Loehe F
Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767
[TBL] [Abstract][Full Text] [Related]
6. Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters.
Cieślak B; Lewandowski Z; Urban M; Ziarkiewicz-Wróblewska B; Krawczyk M
Transplant Proc; 2009 Oct; 41(8):2985-8. PubMed ID: 19857657
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
[TBL] [Abstract][Full Text] [Related]
8. Effect of intermittent hepatic inflow occlusion with the Pringle maneuver during donor hepatectomy in adult living donor liver transplantation with right hemiliver grafts: a prospective, randomized controlled study.
Park JB; Joh JW; Kim SJ; Kwon CH; Chun JM; Kim JM; Moon JI; Lee SK
Liver Transpl; 2012 Jan; 18(1):129-37. PubMed ID: 21837746
[TBL] [Abstract][Full Text] [Related]
9. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation.
Cho JY; Suh KS; Kwon CH; Yi NJ; Cho SY; Jang JJ; Kim SH; Lee KU
Liver Transpl; 2005 Feb; 11(2):210-7. PubMed ID: 15666394
[TBL] [Abstract][Full Text] [Related]
10. Impact of hepatic macrovesicular and microvesicular steatosis on the postoperative liver functions after right hepatectomy in living donors.
Shin YH; Ko JS; Kim GS; Gwak MS; Sim WS; Lee AR; Yi HW; Joh JW
Transplant Proc; 2012 Mar; 44(2):512-5. PubMed ID: 22410058
[TBL] [Abstract][Full Text] [Related]
11. Initial clinical effect of intraportal insulin administration on liver graft regeneration in adult patients underwent living donor right lobe liver transplantation.
Xu MQ; Yan LN; Li B; Wen TF; Zeng Y; Zhao JC; Wang WT; Yang JY; Ma YK; Chen ZY; Zhang ZW
Transplant Proc; 2009 Jun; 41(5):1698-702. PubMed ID: 19545710
[TBL] [Abstract][Full Text] [Related]
12. Expanding postmortem donor pool using steatotic liver grafts: a new look.
Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of reduced-size orthotopic liver transplantation with fatty grafts and its potential regeneration in rats.
Sheng Y; Jiahong D; Benli H
Arch Med Res; 2009 Apr; 40(3):146-55. PubMed ID: 19427964
[TBL] [Abstract][Full Text] [Related]
14. Reversal of graft steatosis after liver transplantation: prospective study.
Li J; Liu B; Yan LN; Zuo YX; Li B; Zeng Y; Zhang SF; Li FG
Transplant Proc; 2009 Nov; 41(9):3560-3. PubMed ID: 19917344
[TBL] [Abstract][Full Text] [Related]
15. Explanted portal vein grafts for middle hepatic vein tributaries in living-donor liver transplantation.
Ikegami T; Soejima Y; Taketomi A; Yoshizumi T; Harada N; Uchiyama H; Shimada M; Maehara Y
Transplantation; 2007 Oct; 84(7):836-41. PubMed ID: 17984835
[TBL] [Abstract][Full Text] [Related]
16. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired.
Cho JY; Suh KS; Kwon CH; Yi NJ; Lee KU
Surgery; 2006 Apr; 139(4):508-15. PubMed ID: 16627060
[TBL] [Abstract][Full Text] [Related]
17. Safety of donors with fatty liver in liver transplantation.
Kwon CH; Joh JW; Lee KW; Kim SJ; Han YS; Park JW; Kim DJ; Park JB; Lee SK
Transplant Proc; 2006 Sep; 38(7):2106-7. PubMed ID: 16980014
[TBL] [Abstract][Full Text] [Related]
18. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short.
Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ
Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740
[TBL] [Abstract][Full Text] [Related]
19. The effect of hyperbaric oxygen treatment on postoperative morbidity of left lobe donor in living donor adult liver transplantation.
Suehiro T; Shimura T; Okamura K; Okada T; Okada K; Hashimoto S; Mochida Y; Kuwano H; Saitoh S; Gotoh F
Hepatogastroenterology; 2008; 55(84):1014-9. PubMed ID: 18705320
[TBL] [Abstract][Full Text] [Related]
20. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation.
Nikeghbalian S; Nejatollahi SM; Salahi H; Bahador A; Sabet B; Jalaeian H; Geramizadeh B; Dehghani SM; Malek-Hosseini SA
Transplant Proc; 2007 May; 39(4):1181-3. PubMed ID: 17524926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
